Current and future approaches to therapy of Alzheimer's disease
- 30 September 1992
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 27 (6) , 565-570
- https://doi.org/10.1016/0223-5234(92)90135-n
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- β-Amyloid and the Pathogenesis of Alzheimer's DiseaseNew England Journal of Medicine, 1991
- Next generation tacrineNeurobiology of Aging, 1991
- The molecular pathology of Alzheimer's diseaseNeuron, 1991
- Diagnostic and Pharmacological Approaches in Alzheimer??s DiseaseDrugs & Aging, 1991
- Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reportedPublished by American Medical Association (AMA) ,1989
- Effects of oral physostigmine in Alzheimer's diseaseAnnals of Neurology, 1987
- Efficacy of oral physostigmine in primary degenerative dementiaPsychopharmacology, 1985
- Analysis of plasma physostigmine concentrations by liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementaNature, 1980
- Galanthamine hydrobromide versus neostigmineAnaesthesia, 1974